Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ninive von Greiff, Lisa Skogens, Marie Berlin & Anders Bergmark. (2018) Mortality and Cause of Death—A 30-Year Follow-Up of Substance Misusers in Sweden. Substance Use & Misuse 53:12, pages 2043-2051.
Read now
Read now
Arto J. Hiltunen, Calle Eklund & Stefan Borg. (2011) The first 38 methadone maintenance treatment patients in Stockholm: 15-year follow-up with a main focus on detoxification from methadone. Nordic Journal of Psychiatry 65:2, pages 106-111.
Read now
Read now
Articles from other publishers (18)
Sarah Brothers, Adam Viera & Robert Heimer. (2021) Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19. Journal of Substance Abuse Treatment 131, pages 108449.
Crossref
Crossref
Jack Stone, Hannah Fraser, April M Young, Jennifer R. Havens & Peter Vickerman. (2020) Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky. International Journal of Drug Policy, pages 102707.
Crossref
Crossref
Phillip L. Marotta & Charlotte A. McCullagh. (2017) A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013. European Journal of Epidemiology 33:7, pages 679-688.
Crossref
Crossref
Angela Russolillo, Akm Moniruzzaman, Lawrence C. McCandless, Michelle Patterson & Julian M. Somers. (2017) Associations between methadone maintenance treatment and crime: a 17‐year longitudinal cohort study of Canadian provincial offenders. Addiction 113:4, pages 656-667.
Crossref
Crossref
José Luis Vázquez López, Lorenz Schild, Thomas Günther, Stefan Schulz, Hartmud Neurath & Axel Becker. (2017) The effects of kratom on restraint–stress-induced analgesia and its mechanisms of action. Journal of Ethnopharmacology 205, pages 178-185.
Crossref
Crossref
Iuliia Makarenko, D. C. Ompad, Y. Sazonova, T. Saliuk, J. DeHovitz & L. Gensburg. (2017) Trends in Injection Risk Behaviors among People Who Inject Drugs and the Impact of Harm Reduction Programs in Ukraine, 2007–2013. Journal of Urban Health 94:1, pages 104-114.
Crossref
Crossref
Georgios Kourounis, Brian David Wensley Richards, Evdokia Kyprianou, Eva Symeonidou, Minerva-Melpomeni Malliori & Lampros Samartzis. (2016) Opioid substitution therapy: Lowering the treatment thresholds. Drug and Alcohol Dependence 161, pages 1-8.
Crossref
Crossref
Martin O. Olsson, Agneta Öjehagen, Louise Brådvik & Anders Håkansson. (2015) Predictors of Psychiatric Hospitalization in Ex-Prisoners With Substance Use Problems. Journal of Drug Issues 45:2, pages 202-213.
Crossref
Crossref
Marcus Blom Nilsson, Deborah Chassler & Lena M. Lundgren. (2015) Factors associated with work and taking prescribed methadone or buprenorphine among Swedish opiate addicts. Evaluation and Program Planning 49, pages 172-177.
Crossref
Crossref
Lena Lundgren, Björn Blom, Deborah Chassler & Lisa M. Sullivan. (2015) Using register data to examine patterns of compulsory addiction treatment care in Sweden: Program planning and methodological implications. Evaluation and Program Planning 49, pages 149-152.
Crossref
Crossref
Sarah Bowman, Julie Eiserman, Leo Beletsky, Sharon Stancliff & R. Douglas Bruce. (2013) Reducing the Health Consequences of Opioid Addiction in Primary Care. The American Journal of Medicine 126:7, pages 565-571.
Crossref
Crossref
Michael Soyka, Anna Träder, Jens Klotsche, Annina Haberthür, Gerhard Bühringer, Jürgen Rehm & Hans‐Ulrich Wittchen. (2012) Criminal Behavior in Opioid‐Dependent Patients Before and During Maintenance Therapy: 6‐year Follow‐Up of a Nationally Representative Cohort Sample. Journal of Forensic Sciences 57:6, pages 1524-1530.
Crossref
Crossref
Sarah Larney, Barbara Toson, Lucy Burns & Kate Dolan. (2011) Effect of prison‐based opioid substitution treatment and post‐release retention in treatment on risk of re‐incarceration. Addiction 107:2, pages 372-380.
Crossref
Crossref
Luis Jimenez-Treviño, Pilar A. Saiz, M. Paz García-Portilla, Eva M. Díaz-Mesa, Fernando Sánchez-Lasheras, Patricia Burón, M. José Casares, Pedro Marina, Eduardo Gutiérrez(†)Julio Bobes. (2011) A 25-year follow-up of patients admitted to methadone treatment for the first time: Mortality and gender differences. Addictive Behaviors 36:12, pages 1184-1190.
Crossref
Crossref
Tyler Pettes, Evan Wood, Silvia Guillemi, Calvin Lai, Julio Montaner & Thomas Kerr. (2010) Methadone use among HIV-positive injection drug users in a Canadian setting. Journal of Substance Abuse Treatment 39:2, pages 174-179.
Crossref
Crossref
M. Fischer, J. Reimer, I. Schäfer & C. Haasen. (2010) Zum Stand der Substitutionstherapie in DeutschlandStatus quo of opioid agonist maintenance therapy in Germany. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 53:4, pages 332-339.
Crossref
Crossref
R. Douglas Bruce. (2010) Methadone as HIV prevention: High Volume Methadone Sites to decrease HIV incidence rates in resource limited settings. International Journal of Drug Policy 21:2, pages 122-124.
Crossref
Crossref
Albert Stuart Reece. (2009) Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine. Journal of Substance Abuse Treatment 37:3, pages 256-265.
Crossref
Crossref